Krisha McKee

Krisha McKee

UNVERIFIED PROFILE

Are you Krisha McKee?   Register this Author

Register author
Krisha McKee

Krisha McKee

Publications by authors named "Krisha McKee"

Are you Krisha McKee?   Register this Author

56Publications

2414Reads

20Profile Views

Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.

Immunity 2019 11 12;51(5):915-929.e7. Epub 2019 Nov 12.

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; International AIDS Vaccine Initiative, Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2019.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891888PMC
November 2019

Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.

Immunity 2019 03 12;50(3):677-691.e13. Epub 2019 Mar 12.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10747613193007
Publisher Site
http://dx.doi.org/10.1016/j.immuni.2019.02.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555550PMC
March 2019

Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition.

Structure 2019 01 21;27(1):196-206.e6. Epub 2018 Nov 21.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry and Molecular Biophysics & Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10032, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09692126183036
Publisher Site
http://dx.doi.org/10.1016/j.str.2018.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664815PMC
January 2019

Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens.

ACS Infect Dis 2018 05 6;4(5):788-796. Epub 2018 Mar 6.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health , 40 Convent Drive , Bethesda , Maryland 20892 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsinfecdis.7b00192DOI Listing
May 2018

Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.

Immunity 2016 Apr 5;44(4):939-50. Epub 2016 Apr 5.

State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Changping District, Beijing 102206, China; Health Science Center, Peking University, Haidian District, Beijing 100191, China; School of Medicine, Nankai University, Nankai District, Tianjin 300071, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2016.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862659PMC
April 2016

Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis.

mBio 2015 Nov 3;6(6):e01375-15. Epub 2015 Nov 3.

Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/mBio.01375-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631801PMC
November 2015

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

Cell 2015 04 9;161(3):470-485. Epub 2015 Apr 9.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry and Molecular Biophysics and Department of Systems Biology, Columbia University, New York, NY 10032, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706178PMC
April 2015

Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.

J Virol 2013 Dec 25;87(24):13239-51. Epub 2013 Sep 25.

IAVI Neutralizing Antibody Center at The Scripps Research Institute, Department of Immunology and Microbial Science, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01247-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838230PMC
December 2013

De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts.

Proc Natl Acad Sci U S A 2013 Oct 8;110(43):E4088-97. Epub 2013 Oct 8.

Vaccine Research Center and NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1306262110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808619PMC
October 2013

Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1.

Structure 2013 Jun 23;21(6):1018-29. Epub 2013 May 23.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.str.2013.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140785PMC
June 2013

HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes.

J Virol 2012 Mar 18;86(6):3393-7. Epub 2012 Jan 18.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.06745-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302320PMC
March 2012

Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.

J Virol 2011 Sep 29;85(17):8954-67. Epub 2011 Jun 29.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00754-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165784PMC
September 2011